Cargando…
Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients
INTRODUCTION: Renal cell carcinoma (RCC), an immunogenic tumor, is the most common form of kidney cancer worldwide. Immune checkpoint inhibitors (ICIs) play an important role in the treatment of metastatic RCC. Programmed death-ligand (PD-L1) has already been proposed as a possible prognosticator fo...
Autores principales: | Mazdak, Mehrdad, Ringlstetter, Rieke, Tabrizi, Pouriya Faraj, Akkoyun, Meryem, Wolters, Mathias, Schmitz, Jessica, Bräsen, Jan Hinrich, Peters, Inga, Kuczyk, Markus Antonius, Tezval, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189971/ https://www.ncbi.nlm.nih.gov/pubmed/34021481 http://dx.doi.org/10.1007/s12325-021-01737-3 |
Ejemplares similares
-
Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma
por: Faraj Tabrizi, Pouriya, et al.
Publicado: (2023) -
DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
por: Katzendorn, Olga, et al.
Publicado: (2021) -
DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma
por: Katzendorn, Olga, et al.
Publicado: (2021) -
Gallbladder carcinosarcoma accompanied with bile duct tumor thrombi: A case report
por: WANG, YAN, et al.
Publicado: (2013) -
Hemopatch(®) as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation
por: Hupe, Marie C., et al.
Publicado: (2020)